SEC Form 4 research
| Issuer | CytomX Therapeutics, Inc. |
|---|---|
| Tickers | CTMX |
| Reporting owners | 56 |
| Officers and directors | 18 |
| Last public filing | 2026-08-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-05 | 2026-08-03 | Carvajal Alejandra | A | 100,000 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Carvajal Alejandra | A | 450,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-24 | Fuchs Charles S. | A | 118,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.